534 related articles for article (PubMed ID: 28481803)
1. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk.
Loch-Wilkinson A; Beath KJ; Knight RJW; Wessels WLF; Magnusson M; Papadopoulos T; Connell T; Lofts J; Locke M; Hopper I; Cooter R; Vickery K; Joshi PA; Prince HM; Deva AK
Plast Reconstr Surg; 2017 Oct; 140(4):645-654. PubMed ID: 28481803
[TBL] [Abstract][Full Text] [Related]
2. The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants.
Magnusson M; Beath K; Cooter R; Locke M; Prince HM; Elder E; Deva AK
Plast Reconstr Surg; 2019 May; 143(5):1285-1292. PubMed ID: 30789476
[TBL] [Abstract][Full Text] [Related]
3. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia: A Longitudinal Study of Implant and Other Related Risk Factors.
Loch-Wilkinson A; Beath KJ; Magnusson MR; Cooter R; Shaw K; French J; Vickery K; Prince HM; Deva AK
Aesthet Surg J; 2020 Jul; 40(8):838-846. PubMed ID: 31738381
[TBL] [Abstract][Full Text] [Related]
4. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
[TBL] [Abstract][Full Text] [Related]
5. U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Doren EL; Miranda RN; Selber JC; Garvey PB; Liu J; Medeiros LJ; Butler CE; Clemens MW
Plast Reconstr Surg; 2017 May; 139(5):1042-1050. PubMed ID: 28157769
[TBL] [Abstract][Full Text] [Related]
6. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
[TBL] [Abstract][Full Text] [Related]
7. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.
Nelson JA; Dabic S; Mehrara BJ; Cordeiro PG; Disa JJ; Pusic AL; Matros E; Dayan JH; Allen RJ; Coriddi M; Polanco TO; Shamsunder MG; Wiser I; Morrow M; Dogan A; Cavalli MR; Encarnacion E; Lee ME; McCarthy CM
Ann Surg; 2020 Sep; 272(3):403-409. PubMed ID: 32694446
[TBL] [Abstract][Full Text] [Related]
8. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
[TBL] [Abstract][Full Text] [Related]
9. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
Cordeiro PG; Ghione P; Ni A; Hu Q; Ganesan N; Galasso N; Dogan A; Horwitz SM
J Plast Reconstr Aesthet Surg; 2020 May; 73(5):841-846. PubMed ID: 32008941
[TBL] [Abstract][Full Text] [Related]
10. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
11. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
12. Public Interest in Textured Breast Implants Recall: A Google Trends Analysis.
Dayani F; Tijerina JD; Morrison SD; Nazerali RS
Aesthetic Plast Surg; 2020 Oct; 44(5):1489-1497. PubMed ID: 32356152
[TBL] [Abstract][Full Text] [Related]
13. Management of Symptomatic Patients with Textured Implants.
Asaad M; Offodile AC; Santanelli Di Pompeo F; Bevers TB; Stelly S; Carew LA; Barnea Y; Miranda RN; Butler CE; Clemens MW
Plast Reconstr Surg; 2021 May; 147(5S):58S-68S. PubMed ID: 33890882
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large T-cell lymphoma and breast implants: a review of the literature.
Jewell M; Spear SL; Largent J; Oefelein MG; Adams WP
Plast Reconstr Surg; 2011 Sep; 128(3):651-661. PubMed ID: 21865998
[TBL] [Abstract][Full Text] [Related]
15. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
[TBL] [Abstract][Full Text] [Related]
16. Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Patients with Textured Tissue Expanders.
Nelson JA; McKernan CD; Rubenstein RN; Shamsunder MG; Poulton R; Dabic S; Mehrara BJ; Disa JJ; Cordeiro PG; McCarthy CM
Plast Reconstr Surg; 2023 Jul; 152(1):32-37. PubMed ID: 36728202
[TBL] [Abstract][Full Text] [Related]
17. A Different Perspective on Breast Implant Surface Texturization and Anaplastic Large Cell Lymphoma (ALCL).
Brown T; Harvie F; Stewart S
Aesthet Surg J; 2019 Jan; 39(1):56-63. PubMed ID: 29659699
[TBL] [Abstract][Full Text] [Related]
18. Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants.
Adams WP; Culbertson EJ; Deva AK; R Magnusson M; Layt C; Jewell ML; Mallucci P; Hedén P
Plast Reconstr Surg; 2017 Sep; 140(3):427-431. PubMed ID: 28841597
[TBL] [Abstract][Full Text] [Related]
19. How Common Is Breast Implant-Associated Anaplastic Large Cell Lymphoma? First Four Cases in Israel.
Ben Naftali Y; Barnea Y; Clemens MW; Bar-Meir E
Isr Med Assoc J; 2019 Aug; 21(8):512-515. PubMed ID: 31474008
[TBL] [Abstract][Full Text] [Related]
20. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
